mRNA |
TPCA-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
OSI-027 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.7 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.7 |
mRNA |
Elesclomol |
GDSC1000 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.7 |
mRNA |
BRD-K48334597 |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.7 |
mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
0.013 |
0.7 |